Cargando…

Distinguishing Between Treatment-Resistant and Non-Treatment-Resistant Schizophrenia Using Regional Homogeneity

Background: Patients with treatment-resistant schizophrenia (TRS) and non-treatment-resistant schizophrenia (NTRS) respond to antipsychotic drugs differently. Previous studies demonstrated that patients with TRS or NTRS exhibited abnormal neural activity in different brain regions. Accordingly, in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Shuzhan, Lu, Shuiping, Shi, Xiaomeng, Ming, Yidan, Xiao, Chaoyong, Sun, Jing, Yao, Hui, Xu, Xijia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088138/ https://www.ncbi.nlm.nih.gov/pubmed/30127752 http://dx.doi.org/10.3389/fpsyt.2018.00282

Ejemplares similares

Enhanced Prefrontal Regional Homogeneity and Its Correlations With Cognitive Dysfunction/Psychopathology in Patients With First-Diagnosed and Drug-Naive Schizophrenia
por: Gao, Shuzhan, et al.
Publicado: (2020)

Abnormal network homogeneity of default-mode network and its relationships with clinical symptoms in antipsychotic-naïve first-diagnosis schizophrenia
por: Kong, Mingjun, et al.
Publicado: (2022)

Hexanucleotide Repeat Expansion in C9ORF72 Is Not Detected in the Treatment-Resistant Schizophrenia Patients of Chinese Han
por: Xu, Xijia, et al.
Publicado: (2015)

The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS)
por: Kinon, Bruce J.
Publicado: (2019)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
por: Amato, Davide, et al.
Publicado: (2019)

Treatment-resistant schizophrenia: How far have we traveled?
por: Pandey, Ambu, et al.
Publicado: (2022)

Metacognitive Training Modulates Default-Mode Network Homogeneity During 8-Week Olanzapine Treatment in Patients With Schizophrenia
por: Shan, Xiaoxiao, et al.
Publicado: (2020)

Magnetic Seizure Therapy in Treatment-Resistant Schizophrenia: A Pilot Study
por: Tang, Victor M., et al.
Publicado: (2018)

Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis
por: Polese, Daniela, et al.
Publicado: (2019)

Sex-Dependent Alterations of Regional Homogeneity in Cigarette Smokers
por: Wen, Zhi, et al.
Publicado: (2022)

Altered Neuroanatomical Signatures of Patients With Treatment-Resistant Schizophrenia Compared to Patients With Early-Stage Schizophrenia and Healthy Controls
por: Liu, Congcong, et al.
Publicado: (2022)

Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics
por: MacKay, Mary-Anne B., et al.
Publicado: (2018)

Methylation Analysis in Monozygotic Twins With Treatment-Resistant Schizophrenia and Discordant Responses to Clozapine
por: Kikuchi, Masataka, et al.
Publicado: (2021)

Managing treatment resistance in schizophrenia: A joint study in Hong Kong and Singapore
por: Zheng, Shushan, et al.
Publicado: (2022)

Disrupted Regional Homogeneity in Drug-Naive Patients With Bipolar Disorder
por: Shan, Xiaoxiao, et al.
Publicado: (2020)

Targeting Treatment-Resistant Auditory Verbal Hallucinations in Schizophrenia with fMRI-Based Neurofeedback – Exploring Different Cases of Schizophrenia
por: Dyck, Miriam S., et al.
Publicado: (2016)

Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia
por: Mostaid, Md Shaki, et al.
Publicado: (2017)

Clinical Course, Neurobiology and Therapeutic Approaches to Treatment Resistant Schizophrenia. Toward an Integrated View
por: Leung, Cheryl Cheuk-Yan, et al.
Publicado: (2019)

Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2021)

Treatment Response Distinguishes Persistent Type of Methamphetamine Psychosis From Schizophrenia Spectrum Disorder Among Inmates at Japanese Medical Prison
por: Sekiguchi, Yosuke, et al.
Publicado: (2021)

Assessment and Treatment of Negative Symptoms in Schizophrenia—A Regional Perspective
por: Bitter, Istvan, et al.
Publicado: (2022)

Remission of Psychosis in Treatment-Resistant Schizophrenia following Bone Marrow Transplantation: A Case Report
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2017)

Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia
por: de Bartolomeis, Andrea, et al.
Publicado: (2020)

Editorial: Neurobiology, Clinical Course, and Therapeutic Approaches of Treatment-Resistant Schizophrenia: Toward an Integrated View
por: Iasevoli, Felice, et al.
Publicado: (2019)

A Case Study Demonstrating Applications of ChatGPT in the Clinical Management of Treatment-Resistant Schizophrenia
por: Galido, Pearl Valentine, et al.
Publicado: (2023)

Case report: Treatment-resistant schizophrenia with auto-aggressive compulsive behavior—Successful management with cariprazine
por: Renemane, Lubova, et al.
Publicado: (2023)

Frequency-Specific Regional Homogeneity Alterations in Tourette Syndrome
por: Lou, Yu-Ting, et al.
Publicado: (2020)

Abnormal Regional Homogeneity in Patients With Obsessive-Compulsive Disorder and Their Unaffected Siblings: A Resting-State fMRI Study
por: Yang, Xiangyun, et al.
Publicado: (2019)

Dissociative Model in Patients With Resistant Schizophrenia
por: Panov, Georgi
Publicado: (2022)

Caregiver Burdens Associated With Treatment-Resistant Schizophrenia: A Quantitative Caregiver Survey of Experiences, Attitudes, and Perceptions
por: Velligan, Dawn I., et al.
Publicado: (2019)

Weight Status Modulated Brain Regional Homogeneity in Long-Term Male Smokers
por: Zhang, Mengzhe, et al.
Publicado: (2022)

Abnormal Default Mode Network Homogeneity in Treatment-Naive Patients With First-Episode Depression
por: Gao, Yujun, et al.
Publicado: (2018)

Ursodeoxycholic Acid in Patients With Treatment-Resistant Schizophrenia Suffering From Coronavirus Disease 2019: A Hypothesis Letter
por: Khosravi, Mohsen
Publicado: (2021)

Disrupted Regional Homogeneity in Major Depressive Disorder With Gastrointestinal Symptoms at Rest
por: Yan, Meiqi, et al.
Publicado: (2021)

Improved Regional Homogeneity in Chronic Insomnia Disorder After Amygdala-Based Real-Time fMRI Neurofeedback Training
por: Li, Zhonglin, et al.
Publicado: (2022)

COVID-19 Pandemic-Delayed Diagnosis and Treatment of Atypical Neuroleptic Malignant Syndrome in a Violent Forensics Patient With Intellectual Disability and Treatment-Resistant Schizophrenia
por: Jan, Mian Zarshawn H, et al.
Publicado: (2023)

Alterations in innate immune defense distinguish first-episode schizophrenia patients from healthy controls
por: Chen, Song, et al.
Publicado: (2022)

Exploring the ability of vocal biomarkers in distinguishing depression from bipolar disorder, schizophrenia, and healthy controls
por: Pan, Wei, et al.
Publicado: (2023)

Comparative Analysis of Lateral Preferences in Patients With Resistant Schizophrenia
por: Panov, Georgi
Publicado: (2022)

Altered Brain Function in Treatment-Resistant and Non-treatment-resistant Depression Patients: A Resting-State Functional Magnetic Resonance Imaging Study
por: Sun, Jifei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_69iq02osvr5k6uodtmtfaoi05m